DuPont to put another $100 million into probiotics production
Yesterday the company’s Nutrition & Health division announced a second phase of an expansion that is already ongoing. Phase one is taking place at facilities in Madison, WI and Rochester, NY and will be partially complete by the end of the year. Phase two, which the company says represents an additional investment of approximately $100 million, will increase the company’s domestic probiotics manufacturing capability by an another 70%. The expansion includes new high-volume fermenters and other processing equipment.
“This investment reinforces our commitment to the probiotics industry. We see strong growth worldwide, and increasing our capacity enables our partners to continue growing and capturing the opportunities from very favorable market trends,” said division president Matthias Heinzel. “As we phase in more capacity, we will continue to maintain the high potency, stability and efficacy in our products.”
DuPont says research from the Natural Marketing Institute puts probiotics awareness at 75% of consumers in the United States. The company said further evidence of worldwide probiotic acceptance is reflected in Euromonitor data that shows an increase in the compound annual growth rate for 2015 to 2020 in every global region – from 4.5% in Asia Pacific to 26% in South America.
